Smithfield Trust’s Impax Laboratories, Inc. IPXL Stock Holding History

Smithfield Trust’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-125	Closed	-$2K	–	1078
2018 Q1	$2K	Hold	125	–	–	﹤0.01%	1011
2017 Q4	$2K	Buy	+125	New	+$2.29K	﹤0.01%	1066
2015 Q4	–	Sell	-3,100	Closed	-$109K	–	873
2015 Q3	$109K	Buy	3,100 +1,110	+56%	+$50K	0.02%	361
2015 Q2	$91K	Buy	+1,990	New	+$94.5K	0.02%	403

Smithfield Trust's IPXL Position: Q2 2018 in Review

Smithfield Trust sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 125 shares — an estimated $2K sold.

Smithfield Trust first reported a position in IPXL in Q2 2015 and held it in 4 quarters. The position peaked at $109K in Q3 2015. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

Smithfield Trust reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
Smithfield Trust sold 125 Impax Laboratories, Inc. shares in Q2 2018, an estimated $2K.
Smithfield Trust first reported a position in Impax Laboratories, Inc. in Q2 2015 and held it in 4 quarters.
Smithfield Trust's Impax Laboratories, Inc. position peaked at $109K in Q3 2015.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Smithfield Trust's 13F filing for Q2 2018, filed 16 Jul 2018.